Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2008 1
2011 2
2012 1
2013 1
2014 3
2015 2
2016 3
2017 1
2018 2
2019 3
2020 3
2021 5
2022 4
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T; patisiran Global OLE study group. Adams D, et al. Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16. Lancet Neurol. 2021. PMID: 33212063 Clinical Trial.
[2020: A year in parentheses].
Campana-Salort E, Bonne G, Allamand V, Andoni Urtizberea J. Campana-Salort E, et al. Med Sci (Paris). 2020 Dec;36 Hors série n° 2:5. doi: 10.1051/medsci/2020268. Epub 2021 Jan 11. Med Sci (Paris). 2020. PMID: 33427627 Free article. French. No abstract available.
HINT1 neuropathy: Expanding the genotype and phenotype spectrum.
Morel V, Campana-Salort E, Boyer A, Esselin F, Walther-Louvier U, Querin G, Latour P, Lia AS, Magdelaine C, Beze-Beyrie P, Behin A, Delague V, Levy N, Stojkovic T, Attarian S, Bonello-Palot N. Morel V, et al. Among authors: campana salort e. Clin Genet. 2022 Nov;102(5):379-390. doi: 10.1111/cge.14198. Epub 2022 Aug 16. Clin Genet. 2022. PMID: 35882622 Free PMC article. Review.
Non-traumatic rhabdomyolysis and diabetes.
Sani MA, Campana-Salort E, Begu-LeCorroller A, Baccou M, Valéro R, Vialettes B. Sani MA, et al. Among authors: campana salort e. Diabetes Metab. 2011 Jun;37(3):262-4. doi: 10.1016/j.diabet.2011.03.003. Epub 2011 May 7. Diabetes Metab. 2011. PMID: 21550832
[Which follow-up for innovative treatments?].
Campana-Salort E, Espil-Taris C, Prigent H, de Antonio M, Lebrun-Vignes B, Tiffreau V, Honnet G. Campana-Salort E, et al. Med Sci (Paris). 2019 Mar;35 Hors série n° 1:54-56. doi: 10.1051/medsci/2019053. Epub 2019 Apr 3. Med Sci (Paris). 2019. PMID: 30943166 Free article. French. No abstract available.
Improving outcome measures in late onset Pompe disease: Modified Rasch-Built Pompe-Specific Activity scale.
van Kooten HA, Horton MC, Wenninger S, Babačić H, Schoser B, Lefeuvre C, Taouagh N, Laforêt P, Segovia S, Díaz-Manera J, Claeys KG, Mongini T, Musumeci O, Toscano A, Hundsberger T, Brusse E, van Doorn PA, van der Ploeg AT, van der Beek NAME; European Pompe Consortium study group on outcome measures. van Kooten HA, et al. Eur J Neurol. 2024 Dec;31(12):e16397. doi: 10.1111/ene.16397. Epub 2024 Aug 28. Eur J Neurol. 2024. PMID: 39205420 Free PMC article.
28 results